Library

Safety guides, dosing protocols, reconstitution math, and plain-English references for every peptide in the category.

Dosing protocols

In short: BPC-157 has 200+ animal studies, zero completed human efficacy trials, and a research-chem-only supply chain — the gap between hyp

The CARS-2013 trial (NCT01215708) enrolled 208 patients with acute ischemic stroke and delivered Cerebrolysin 30 mL intravenously once daily

CJC-1295 without the drug-affinity complex (commonly labeled "CJC-1295 no-DAC" or by its original research designation "Modified GRF 1-29")

In short: GHK-Cu has the strongest topical-dermatology evidence of any peptide on TriedRx and the thinnest injectable human data — the case

Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) developed in the late 1990s as a selective growth hormone secretagogu

In short: PT-141 is the active ingredient in Vyleesi, FDA-approved for female HSDD at a fixed 1.75 mg subcutaneous dose — and it's also wide

The phase 2 retatrutide obesity trial (n = 338) reported a mean body weight reduction of 24.2% at 48 weeks on the 12 mg weekly dose, the lar

The STEP 1 trial randomized 1,961 adults with obesity to semaglutide 2.4 mg weekly or placebo and reported a mean body weight reduction of 1

Elamipretide (SS-31, Bendavia, MTP-131) is a water-soluble, mitochondria-targeted tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) that selectively bind

In short: TB-500 is a short fragment of thymosin beta-4 dosed in the low-milligram range weekly, supported by preclinical Tβ4 data — but the

SURMOUNT-1 randomized 2,539 adults with obesity to tirzepatide 5, 10, or 15 mg weekly or placebo for 72 weeks, and the 15 mg arm reported a